Delivery Order SPE2DB22D3016-SPE2DB25FBDY0
- Not listed
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine oral syringes (1.5 ml) under a firm fixed-price contract valued at $6,653.06. The award was made on May 15, 2025, with an ultimate completion date of May 16, 2025. This delivery order is issued without a set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5mL) under a firm fixed-price contract valued at $11,462.30. The order, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a non-competitive, non-set-aside delivery of pharmaceutical products to support federal medical supply requirements. Performance will take place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5 mL) with a ceiling value of $1,476.68. This non-set-aside, firm fixed price delivery order was awarded on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine oral syringes (1.5ml) under a firm fixed-price contract valued at $8,859.96. The award was made on August 20, 2025, with an ultimate completion date of August 21, 2025, and represents a competitively awarded, non-set-aside delivery order. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $26,579.88 delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5 mL) on September 2, 2025, with completion scheduled for September 3, 2025. This competitively awarded, firm fixed-price contract represents a small component of the vendor's extensive pharmaceutical supply operations supporting federal medical procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Rotarix Vaccine Oral Syringe 1.5ML, with a ceiling value of $6,750.09. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by August 5, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents no set-aside designation, indicating open competition among qualified vendors. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Rotarix Vaccine Oral Syringe 1.5ml with a ceiling value of $39,804.60. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,067.22 to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine oral syringes (1.5mL) with a firm fixed price structure. The contract, which was competitively awarded with no set-aside designation, is scheduled for ultimate completion on April 25, 2025, one day after the award date of April 24, 2025. Performance will be fulfilled from AmerisourceBergen's facility located in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Rotarix vaccine oral syringes in 1.5mL units, with a ceiling value of $5,527.46. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rotarix Vaccine oral syringes (1.5mL) under a firm fixed-price contract valued at $8,212.02, with a completion date of September 2, 2025. This non-set-aside, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The delivery order will be...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBDY0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine oral syringes (1.5 mL) under a firm fixed price contract with a ceiling value of $31,767.42. The award was made on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This is an unset-aside, competitively awarded delivery order reflecting the agency's procurement requirements for this specific vaccine delivery device. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including vaccines, medications, medical devices, and specialized healthcare commodities. The company's contract portfolio demonstrates consistent capability in fulfilling federal procurement requirements through open competition across multiple therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.8k | 8/4/25 |